| Literature DB >> 33270031 |
Inmaculada Grau-Corral1,2, Pau Gascon1,2, Francisco J Grajales Iii1,3, Belchin Kostov4, Antoni Sisó Almirall4,5,6.
Abstract
BACKGROUND: The number of medical and health apps in the App Store and Google Play repositories has been increasing in the recent years, and most of these apps are in English. However, little is known about the domain of Spanish health apps and their evolution.Entities:
Keywords: Google Advanced Search; apps; evaluation studies; health apps; mHealth assessment; mobile apps, Spanish apps; mobile health; mobile phone; patient apps; ratings
Mesh:
Year: 2020 PMID: 33270031 PMCID: PMC7746492 DOI: 10.2196/17139
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Details of the number of apps collected over the years in this study.
| Description | Year 2014 | Year 2015 | Year 2016 | Year 2017 | Year 2018 |
| Apps collected (n=1377) | 247 | 280 | 280 | 271 | 280 |
| Apps that met inclusion criteria (n=210) | 26 | 55 | 42 | 48 | 39 |
Figure 1Flowchart of the selection of apps.
Evolution of the health apps included each year, classified by 14 ICD-10a disease groups (n=210).
| Apps as per ICD-10 | Number of apps in each year | ||||
|
| Year 2014 (n=26) | Year 2015 (n=55) | Year 2016 (n=42) | Year 2017 (n=48) | Year 2018 (n=39) |
| Infectious and parasitic diseases (n=16) | 1 | 6 | 3 | 2 | 4 |
| Cancer (n=21) | 4 | 8 | 5 | 2 | 2 |
| Blood diseases (n=8) | 1 | 2 | 2 | 1 | 2 |
| Endocrine, nutritional and metabolic diseases (n=32) | 5 | 6 | 5 | 11 | 5 |
| Mental and behavioral disorders (n=8) | 1 | 2 | 2 | 2 | 1 |
| Diseases of the nervous system (n=28) | 4 | 8 | 5 | 5 | 6 |
| Eye diseases (n=11) | 1 | 4 | 2 | 2 | 2 |
| Ear diseases (n=12) | 0 | 4 | 2 | 3 | 3 |
| Circulatory system diseases (n=12) | 2 | 3 | 2 | 3 | 2 |
| Diseases of the respiratory system (n=18) | —b | 3 | 3 | 6 | 6 |
| Diseases of the digestive system (n=12) | 1 | 3 | 3 | 3 | 2 |
| Skin diseases (n=11) | 3 | 2 | 3 | 3 | 0 |
| Diseases of the musculoskeletal system (n=12) | 3 | 2 | 2 | 3 | 2 |
| Genitourinary system diseases (n=9) | 0 | 2 | 3 | 2 | 2 |
aICD-10: International Classification of Diseases, Tenth Revision.
bNot available.
Reasons for app exclusion.a
| Reasons, operating systems | Number of apps in each year | |||||
|
| Year 2014 | Year 2015 | Year 2016 | Year 2017 | Year 2018 | |
|
| ||||||
|
| Android (n=182) | 36 | 64 | 15 | 40 | 27 |
|
| iOSb (n=141) | 5 | 51 | 43 | 24 | 18 |
|
| Total | 41 | 115 | 58 | 64 | 45 |
|
| ||||||
|
| Android (n=114) | 36 | 20 | 47 | 7 | 4 |
|
| iOS (n=117) | 54 | 37 | 16 | 7 | 3 |
|
| Total | 90 | 57 | 63 | 14 | 7 |
|
| ||||||
|
| Android (n=106) | 54 | 11 | 22 | 10 | 9 |
|
| iOS (n=121) | 30 | 19 | 28 | 15 | 29 |
|
| Total | 84 | 30 | 50 | 25 | 38 |
|
| ||||||
|
| Android (n=80) | 54 | 7 | 6 | 2 | 11 |
|
| iOS (n=76) | 56 | 3 | 10 | 2 | 5 |
|
| Total | 110 | 10 | 16 | 4 | 16 |
|
| ||||||
|
| Android (n=37) | 0 | 1 | 2 | 5 | 29 |
|
| iOS (n=14) | 0 | 1 | 4 | 4 | 5 |
|
| Both (n=63) | 2 | 6 | 22 | 12 | 21 |
|
| Total | 2 | 8 | 28 | 21 | 55 |
|
| ||||||
|
| Android (n=88) | —c | — | 21 | 36 | 31 |
|
| iOS (n=64) | — | — | 2 | 20 | 42 |
|
| Total | — | — | 23 | 56 | 73 |
|
| ||||||
|
| Android (n=76) | — | — | 19 | 33 | 24 |
|
| iOS (n=8) | — | — | 0 | 6 | 2 |
|
| Total | — | — | 19 | 39 | 26 |
|
| ||||||
|
| Android (n=57) | 13 | 23 | 12 | 5 | 4 |
|
| iOS (n=70) | 22 | 24 | 6 | 11 | 7 |
|
| Total | 35 | 47 | 18 | 16 | 11 |
aThere may be more than one reason for exclusion of apps.
biOS: iPhone operating system.
cNot available.
Stability of the results through the years.
| Number of apps | Year 2014 | Year 2015 | Year 2016 | Year 2017 | Year 2018 | Total | Repeated apps | Apps without |
| Annual results (n) | 26 | 55 | 42 | 48 | 39 | 210 | 74 | 136 |
| Apps disappeared in 2019, n (%) | 12 (46) | 18 (33) | 10 (24) | 4 (8) | 0 (0) | 44 (20.9) | 7 (10) | 37 (27.2) |
| Apps remaining in 2019 (n) | 14 | 37 | 32 | 44 | 39 | 166 | N/Aa | 99 |
aN/A: Not applicable.
Stability of the results through the years by group of disease (n=210).
| ICD-10a group | Repeated apps (n=74) | Unique apps without repetition (n=136) | Stability ratio | Disappeared apps, n (%) | Apps in 2019 (n=99) |
| Infectious and parasitic diseases (n=16) | 6 | 10 | 1.6 | 2 (20) | 8 |
| Cancer (n=21) | 8 | 13 | 1.6 | 7 (54) | 6 |
| Blood diseases (n=8) | 3 | 5 | 1.6 | 2 (40) | 3 |
| Endocrine, nutritional and metabolic diseases (n=32) | 16 | 16 | 2.0 | 2 (13) | 14 |
| Mental and behavioral disorders (n=8) | 1 | 7 | 1.1 | 3 (43) | 4 |
| Diseases of the nervous system (n=28) | 13 | 15 | 1.9 | 5 (33) | 10 |
| Eye diseases (n=11) | 2 | 9 | 1.2 | 0 (0) | 9 |
| Ear diseases (n=12) | 1 | 11 | 1.1 | 2 (18) | 9 |
| Circulatory system diseases (n=12) | 3 | 9 | 1.3 | 4 (44) | 5 |
| Diseases of the respiratory system (n=18) | 6 | 12 | 1.5 | 2 (17) | 10 |
| Diseases of the digestive system (n=12) | 4 | 8 | 1.5 | 5 (63) | 3 |
| Skin diseases (n=11) | 3 | 8 | 1.4 | 1 (13) | 7 |
| Diseases of the musculoskeletal system (n=12) | 3 | 9 | 1.3 | 1 (11) | 8 |
| Genitourinary system diseases (n=9) | 5 | 4 | 2.3 | 1 (25) | 3 |
aICD-10: International Classification of Diseases, Tenth Revision.
Native Spanish apps and apps that were translated from other languages to Spanish (n=136).
| Language type of apps, availability | Values, n (%) | ||
|
| |||
|
| Available | 55 (69) | |
|
| Not available | 25 (31) | |
| Subtotal | 80 (58.8) | ||
|
| |||
|
| Available | 44 (79) | |
|
| Not available | 12 (21) | |
| Subtotal | 56 (41.2) | ||
Apps selected and classified by promoter (n=136).
| Promoter type and availability | Values, n (%) | |
|
| ||
|
| Available | 7 (70) |
|
| Not available | 3 (30) |
|
| Subtotal | 10 (7.3) |
|
| ||
|
| Available | 36 (82) |
|
| Not available | 8 (18) |
|
| Subtotal | 44 (32.3) |
|
| ||
|
| Available | 7 (64) |
|
| Not available | 4 (36) |
|
| Subtotal | 11 (8.1) |
|
| ||
|
| Available | 25 (69) |
|
| Not available | 11 (31) |
|
| Subtotal | 36 (26.5) |
|
| ||
|
| Available | 7 (70) |
|
| Not available | 3 (30) |
|
| Subtotal | 10 (7.3) |
|
| ||
|
| Available | 15 (60) |
|
| Not available | 10 (40) |
| Subtotal | 25 (18.4) | |